Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to assess the safety of Ipilimumab monotherapy in Japanese subjects with advanced melanoma
Epistemonikos ID: fa5683334b3f7887a9cc516a7c564468bfdd6c95
First added on: May 13, 2020